Brain-Responsive Device Cuts Seizures Over Three Years

What was studied

This study looked at the effectiveness and safety of a brain-responsive device called the RNS System for treating focal epilepsy. It involved 324 adult participants from 32 epilepsy centers in the United States who were implanted with the device and followed for three years.

The main goal was to see how much the device could reduce seizure frequency over time. The researchers measured the change in seizure frequency at 6 months and again at 3 years after treatment.

What they found

The study found that the RNS System was associated with a reduction in seizure frequency. On average, seizures were reduced by 62% after 6 months and by 82% after 3 years. Additionally, 41% of participants had a reduction of 90% or more in their seizures, and 22% experienced no seizures for 12 months or longer. The device was well-tolerated, with no serious stimulation-related adverse events reported.

Limits of the evidence

The study cannot prove that the device will work for everyone, as it only included adults with specific types of epilepsy. The long-term safety results will be fully analyzed after 5 years, so more information is needed about the device's effects over a longer period.

For families and caregivers

This information may be important for families considering treatment options for focal epilepsy. The RNS System shows potential in reducing seizures significantly and appears to be safe based on this study.

What to watch next

Future studies could explore how to personalize the device's settings for better outcomes.